Pfizer applies for emergency coronavirus vaccine approval in U.S.

It comes days after the drugmaker announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

This entry was posted in Main. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *